­
Our Portfolio

Asia SPAC Pioneer

Selected Case Study

NASDAQ

DT Asia

NASDAQ

Inception Growth

NASDAQ

AGBA

NASDAQ

Phoenix

NASDAQ

Tottenham

NASDAQ

Ace Global 2

HKEX

Ace 8

NASDAQ

Atlas

NASDAQ

Ace Global

NASDAQ

Heroic

NASDAQ

Keen Vision
CASE STUDY 1

DT Asia Investments Limited

DT Asia Investments Limited (NASDAQ: CADT) went public in the U.S. as a SPAC and was awarded the Best IPO of 2014 by Acquisition International.

DT Asia Investments Limited was one of the few U.S. SPACs targeting the Asian market after the 2008 financial crisis.

Following the business combination, the newly-formed entity now operates under the name Lending Group (later renamed Roan Holdings Group Co., Ltd., NASDAQ: RAHGF), a direct lending company based in the Xinjiang Uyghur Autonomous Region of China.

Merger Completion Date

July 6, 2016

CASE STUDY 2

Tottenham Acquisition I Limited

Tottenham Acquisition I Limited (TOTA) went public on the U.S. Nasdaq, marking itself as the pioneer among Asia-backed SPACs to complete a merger with a U.S.-based biopharmaceutical company.

Following the business combination, the newly-formed entity now operates under the name Clene Inc. (NASDAQ: CLNN), with a primary focus on developing innovative therapeutic candidates for neurodegenerative diseases.

Clene has an exceptional management team, robust shareholder and advisory backgrounds, extensive professional expertise in biotechnology, and substantial intellectual property, creating significant entry barriers.

Merger Completion Date

December 30, 2020

CASE STUDY 3

Keen Vision Acquisition Corporation

Keen Vision Acquisition Corporation (NASDAQ: KVAC) made its debut on NASDAQ on July 24, 2023, with nearly four times oversubscription. In March 2024, KVAC signed a letter of intent for business combination with a Boston-based biopharmaceutical firm.

The company specializes in developing cutting-edge human stem cell technology and next-gen cell/gene therapies for challenging diseases. Its pipeline, FDA-approved, is undergoing clinical trials at leading US hospitals.

Completed Listing and Signed Merger Agreement

A boutique SPAC firm with extensive US and Hong Kong experience, specializing in sponsoring, fund-raising, listing, and corporate merger support.

Follow Us

© Norwich. 2024. All Right Reserved.